3rd Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$1,770,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

- Issues regarding the theft of medical products.

LobbyistCovered position, as disclosed
JULIE D COHEN New —
MARK REESE —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE

Copyright/Patent/Trademark CPT

- HR 1249, "The America Invents Act", regarding all provisions.

LobbyistCovered position, as disclosed
CHARLES NAU —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Bills named: H.R. 1249 (112th)

Budget/Appropriations BUD

- Issues related to ADAP funding.

LobbyistCovered position, as disclosed
CHARLES NAU New —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

- Korea-US Free Trade Agreement - Issues related to current and future trade negotiations. - TransPacific Partnership trade negotiations.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH Committee; Legislative Asst., Rep. Thomas

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE

Taxation/Internal Revenue Code TAX

- Issues regarding tax reform. - HR 605, "The Patients' Freedom to Choose Act", regarding all provisions. - HR 436, "Protect Medical Innovation Act of 2011", regarding all provisions. - HR 488, "Save Our Medical Devices Act of 2011", regarding all provisions. - HR 734, "To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes", regarding all provisions. - S 17, "Medical Device Access and Innovation Protection Act", regarding all provisions. - S 262, "A bill to repeal the excise tax on medical device manufacturers", regarding all provisions. - HR 942, "American Research and Competitiveness Act of 2011", regarding all provisions - Issues related to tax legislation. - Issues related to the President's proposed "Job Bill" (2011) - S 1368/ HR 2529, "Restoring Access to Medication Act", regarding all provisions. - S 1584, "Drug Safety and Accountability Act of 2011", regarding all provisions. - HR 2245, "Preserving Access to Life-Saving Medication Act", regarding all provisions.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DON BOHN —
BRIAN BURNS —
DARREL C JODREY —
DAVID KAVANAUGH New —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 2529 (112th), H.R. 605 (112th), H.R. 734 (112th), H.R. 942 (112th), H.R. 2245 (112th), H.R. 436 (112th), H.R. 488 (112th)

Medicare/Medicaid MMM

- Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - HR 905/ S 733, "To Amend Part B or Title XVIII of the Social Security Act to exclude customary prompt pay discounts from Manufacturers to Wholesalers from the average sales price for drugs & biologicals under Medicare", regarding all provisions. - HR 1041, "The Fairness in Medicare Bidding Act", regarding all provisions. - HR 1041, "Fairness in Medicare Bidding Act", regarding all provisions. - Medicare Part D Letter - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - S 668, "Health Care Bureaucrats Elimination Act", regarding all provisions. - Issues related to Physician-owned Companies. - S 1468/ HR 2787, "Medicare Diabetes Self-Management Training Act of 2011", regarding all provisions.

LobbyistCovered position, as disclosed
KIMBERLY DAVIS —
LAURYL DODSON JACKSON —
DARREL C JODREY —
MARK REESE —

Contacted: SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 905 (112th), H.R. 2787 (112th), H.R. 1041 (112th), H.R. 452 (112th)

Environment/Superfund ENV

- Issues related to chemicals in the environment - Issues related to the Toxic Substances Control Act - S. 847, "Safe Chemicals Act of 2011", regarding all provisions.

LobbyistCovered position, as disclosed
GREGORY ARONIN —
DARREL C JODREY —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR)

Bills named: S. 847 (112th)

Consumer Issues/Safety/Products CSP

- Issues related to dextromethorphan - Issues related to Pseudoephedrine - Issues related to the regulation of Cosmetic Products. - Issues relating to the McNeil recall of over the counter medications - HR 2359, "Safe Cosmetics Act of 2011", regarding all provisions.

LobbyistCovered position, as disclosed
GREGORY ARONIN New —
DON BOHN —
DARREL C JODREY —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2359 (112th)

Torts TOR

- HR 5, "Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011", regarding all provisions. - HR 675, "Strengthening Medicare Anti-Fraud Measures Act of 2011", regarding all provisions. - Issues regarding Health Courts

LobbyistCovered position, as disclosed
GREGORY ARONIN —

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC)

Bills named: H.R. 5 (112th), H.R. 675 (112th)

Health Issues HCR

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - Issues regarding personalized medicine - Issues related to the Medical Device User Fee Program. - Issues related to the Better Act - Issues related to the Personalized Medicine Bill - Issues related to Diagnostics. - S. 1001, "Safe Doses Act", regarding all provisions. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Physician Drug User Fee Act, regarding all provisions - MODERN Cures Act, regarding all provisions. - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
BRIAN BURNS —
JULIE D COHEN —
KIMBERLY DAVIS —
LAURYL DODSON JACKSON —
DARREL C JODREY —
CHARLES NAU New —
MARK REESE —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC)

Bills named: S. 1001 (112th), H.R. 1282 (112th), H.R. 2960 (112th), H.R. 3026 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.